These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 72199)

  • 1. Predicting patients' warfarin requirements.
    Routledge PA; Davies DM; Bell SM; Cavanagh JS; Rawlins MD
    Lancet; 1977 Oct; 2(8043):854-5. PubMed ID: 72199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating patients' warfarin requirements.
    Jones BR; Baran A; Reidenberg MM
    J Am Geriatr Soc; 1980 Jan; 28(1):10-2. PubMed ID: 7350210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting the dose of warfarin for therapeutic anticoagulation.
    Sharma NK; Routledge PA; Rawlins MD; Davies DM
    Thromb Haemost; 1982 Jun; 47(3):230-1. PubMed ID: 7112495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of prothrombin time and thrombotest and hepaplastin test for the control of oral anticoagulant therapy].
    Murakami S; Muratani H; Kikuchi T; Fujimoto S; Hayashi T; Inai S; Imaoka S
    Rinsho Byori; 1983 Feb; 31(2):210-4. PubMed ID: 6855001
    [No Abstract]   [Full Text] [Related]  

  • 5. A flexible loading dose schedule for warfarin therapy.
    Fergusson RJ; Eade OE; Logie AW; Gaddie J
    Scott Med J; 1987 Dec; 32(6):169-71. PubMed ID: 3329767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Warfarin dose requirements with different genotypes of CYP2C9 and VKORC1 for patients with atrial fibrillation and valve replacement.
    Chen W; Wu L; Liu X; Shen Y; Liang Y; Zhu J; Tan H; Yang Y; Liu Q; Wang M; Liu L; Wang X
    Int J Clin Pharmacol Ther; 2017 Feb; 55(2):126-132. PubMed ID: 27117036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of anticoagulant control in patients receiving warfarin.
    O'Malley K; Stevenson IH; Ward CA; Wood AJ; Crooks J
    Br J Clin Pharmacol; 1977 Jun; 4(3):309-14. PubMed ID: 901698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of valve thrombosis of CarboMedics prosthesis four years after mitral valve replacement: relationship of anticoagulant therapy to coagulation and fibrinolysis activating factors].
    Morishita A; Harada M; Hara M
    Kyobu Geka; 1996 Oct; 49(11):933-7. PubMed ID: 8913069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited dose warfarin throughout pregnancy in patients with mechanical heart valve prosthesis: a meta-analysis.
    Hassouna A; Allam H
    Interact Cardiovasc Thorac Surg; 2014 Jun; 18(6):797-806. PubMed ID: 24595247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective study of an aggressive warfarin dosing algorithm to reach and maintain INR 2 to 3 after heart valve surgery.
    Meijer K; Kim YK; Carter D; Schulman S
    Thromb Haemost; 2011 Feb; 105(2):232-8. PubMed ID: 21173999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between Normotest and Thrombotest in patients on oral anticoagulant therapy.
    Refsum N; Arnesen H; Gilhuus-Moe CC; Godal HC
    Scand J Haematol; 1977 Apr; 18(4):333-6. PubMed ID: 854707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of long-term oral anticoagulant therapy and its laboratory assessment.
    Eastham RD
    J Clin Pathol; 1975 Mar; 28(3):198-201. PubMed ID: 1123447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apixaban Versus Warfarin for Mechanical Heart Valve Thromboprophylaxis in a Swine Aortic Heterotopic Valve Model.
    Lester PA; Coleman DM; Diaz JA; Jackson TO; Hawley AE; Mathues AR; Grant BT; Knabb RM; Ramacciotti E; Frost CE; Song Y; Wakefield TW; Myers DD
    Arterioscler Thromb Vasc Biol; 2017 May; 37(5):942-948. PubMed ID: 28232327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulation After Biological Aortic Valve Replacement: Is There An Optimal Regimen?
    Owais T; Rouman M; Breuer M; Hüter L; Fuchs J; Lauer B; Kuntze T
    J Heart Valve Dis; 2016 Mar; 25(2):139-144. PubMed ID: 27989055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Blood coagulation after replacement of heart valves--cases with relatively early administration of anticoagulants].
    Nagasaki Y
    Igaku Kenkyu; 1974 Aug; 44(5):461-80. PubMed ID: 4478043
    [No Abstract]   [Full Text] [Related]  

  • 16. [Warfarin in the treatment of antiphospholipid syndrome].
    Reshetniak TM; Kondrat'eva LV; Patrusheva NL; Patrushev LI
    Ter Arkh; 2007; 79(5):47-54. PubMed ID: 17672075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transition from acenocoumarol to warfarin in a 12-year-old child.
    Hakacova N; Björkhem G; Hanséus K
    Congenit Heart Dis; 2011; 6(6):661-4. PubMed ID: 21501391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitral disc valve implantation in the dog: early and late valve thrombosis and its prevention.
    Dale J; Aasen AO; Resch F; Semb B; Stadskleiv K; Lilleaasen P
    Eur Surg Res; 1983; 15(5):249-55. PubMed ID: 6617707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of age with dosage requirement for warfarin.
    Redwood M; Taylor C; Bain BJ; Matthews JH
    Age Ageing; 1991 May; 20(3):217-20. PubMed ID: 1906677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting warfarin maintenance dosage based on initial response.
    Miller DR; Brown MA
    Am J Hosp Pharm; 1979 Oct; 36(10):1351-5. PubMed ID: 507078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.